secwatch.observer — SEC 8-K summary
======================================

Issuer:     Iterum Therapeutics plc (ITRMF)
CIK:        0001659323
Form:       8-K
Filed at:   2023-12-04T23:59:59+00:00
Accession:  0000950170-23-067481
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Iterum regains Nasdaq compliance with minimum bid price rule
------------------------------------------------------------

- Received letter from Nasdaq on Dec 4, 2023 confirming compliance with Bid Price Rule.
- Previously notified of deficiency on Sept 26, 2023; compliance deadline was March 25, 2024.
- Achieved minimum $1.00 closing bid price for 10 consecutive trading days through Nov 30, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659323/000095017023067481/0000950170-23-067481-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659323/000095017023067481/itrm-20231204.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-067481

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer